Gray/White Matter Contrast in Parkinson’s Disease

Gray/white matter contrast (GWC) decreases with aging and has been found to be a useful MRI biomarker in Alzheimer’s disease (AD), but its utility in Parkinson’s disease (PD) patients has not been investigated. The aims of the study were to test whether GWC is sensitive to aging changes in PD patien...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Front Aging Neurosci
Hoofdauteurs: Uribe, Carme, Segura, Barbara, Baggio, Hugo C., Abos, Alexandra, Garcia-Diaz, Anna I., Campabadal, Anna, Marti, Maria J., Valldeoriola, Francesc, Compta, Yaroslau, Bargallo, Nuria, Junque, Carme
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Frontiers Media S.A. 2018
Onderwerpen:
Neuroscience
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5881246/
https://ncbi.nlm.nih.gov/pubmed/29636679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnagi.2018.00089
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items